New Delhi, Nov. 4 (PTI): An apex board under the central drug regulatory authority has recommended doing away with the requirement of a prescription for buying Refresh Tears, a medicine for dry eyes. Allergan India Pvt Ltd had approached the Drugs Technical Advisory Board (DTAB) with a representation in the matter so that the medicine can be bought over the counter. It submitted that ‘Refresh Tears’, which contains Carboxymethylcellulose Sodium eye drops 0.5 per cent w/v sterile ophthalmic solution, is for temporary relief from burning, irritation and discomfort due to dryness of the eyes or exposure to wind or sun and may be used as a protectant against further irritation. “The board after detailed deliberation agreed to remove the requirement of a prescription from a registered medical practitioner in respect of drug product ‘Refresh Tears’ for its retail sale. Accordingly, relevant provisions of the rules may be amended,” according to minutes of a